Submitted by mike kraft on
As the U.S. grapples with record hospitalizations and deaths from the Covid-19 pandemic, a crucial vaccination rollout campaign is being impeded by inconsistent messaging and myriad state strategies as a new variant of the virus drives up infection rates, according to public health experts.
Submitted by mike kraft on
New York’s governor threatened to fine hospitals if they don’t use their allotment of COVID-19 vaccine fast enough. His South Carolina counterpart warned health care workers they have until Jan. 15 to get a shot or move to the back of the line. California’s governor wants to use dentists to vaccinate people.
Submitted by mike kraft on
With no robust system to identify genetic variations of the coronavirus, experts warn that the United States is woefully ill-equipped to track a dangerous new mutant, leaving health officials blind as they try to combat the grave threat.
The variant, which is now surging in Britain and burdening its hospitals with new cases, is rare for now in the United States. But it has the potential to explode in the next few weeks, putting new pressures on American hospitals, some of which are already near the breaking point.
Submitted by mike kraft on
Submitted by mike kraft on
CVS and Walgreens are currently administering the vaccine in long-term care facilities in 49 states, Washington D.C. and Puerto Rico. Around 35,000 long-term care facilities have partnered with Walgreens, and nearly 8,000 with CVS.
The companies, which run the nation’s largest pharmacy chains but also offer other offsite pharmacy services, have an agreement with the federal government to vaccinate U.S. nursing home residents through a voluntary program.
CVS said most of the residents and staff will be fully vaccinated within three to four weeks of the first visit, depending on the vaccine they receive.
In addition to nursing homes, CVS said it will vaccinate residents and staff at assisted-living facilities, with nearly 31,000 such centers partnering with the company.
####
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
AMSTERDAM (AP) — The European Union’s medicines agency gave the green light Wednesday to Moderna Inc.’s COVID-19 vaccine, a decision that gives the 27-nation bloc a second vaccine to use in the desperate battle to tame the virus rampaging across the continent.
Submitted by mike kraft on
Submitted by mike kraft on
WASHINGTON — Federal officials and drugmakers, faced with a slower-than-expected rollout of the coronavirus vaccine, are racing to find ways to expand the supply, looking at lowering the required dosage and extracting more doses from the supplies they have.
Just weeks into the vaccine program, scientists at the National Institutes of Health and the drugmaker Moderna are analyzing data to see if they can double the supply of the company’s coronavirus vaccine by cutting doses in half. The study, though long planned, is increasingly urgent in the face of looming shortages as the country tries to fight off a surging pandemic.
